Synthesis of constrained thiorphan analogs as inhibitors of neutral endopeptidase

Bioorganic and Medicinal Chemistry Letters

Volumn 6, Issue 17, 1996, Pages 2053-2058

  Beight, Douglas W ^a   Mehdi, Shujaath ^a   Koehl, Jack R ^a   Flynn, Gary A ^a  

^a SANOFI   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ENZYME INHIBITOR; MEMBRANE METALLOENDOPEPTIDASE; THIORPHAN; THIORPHAN DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; CHIRALITY; DRUG DESIGN; DRUG STRUCTURE; DRUG SYNTHESIS; ENZYME BINDING; ENZYME INHIBITION; MOLECULAR MODEL; NUCLEAR MAGNETIC RESONANCE;

EID: 0030567870     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/0960-894X(96)00367-8     Document Type: Article

References (25)

1. Beight, D. W.; Mehdi, S.; Koehl, J. R.; Flynn, G.A. Presented in preliminary form at the 203rd National Meeting of the American Chemical Society, Washington, DC, August 1992.
2. Laragh, J. H.; Brenner, B. M. Hypertension: Pathophysiology, Diagnosis, and Management, Second Edition; Raven: New York, 1995, pp 3099-3114.
3. For a review on ANF metabolism see: Schwartz, J. C.; Gros, C.; Lecomte, J. M.; Bralet, J. Life Sci. 1990, 47, 1279.
4. (a) Malfroy, B.; Swerts, J. P.; Guyon, A.; Roques, B. P.; Schwartz, J. C. Nature (London) 1978, 276, 523.
5. (b) Roques, B. P.; Fournié-Zaluskie, M. C.; Soroca, E.; Lecomte, J. M.; Malfroy, B.; Llorens, C.; Schwartz, J. C. Nature (London) 1980, 288, 286.
6. Greenberg, R.; O'Keefe, E. H. Life Sci. 1982, 31, 1185.
7. Chipkin, R. C.; Latranyi, M. B.; Iorio, L. C. Life Sci. 1982, 31, 1189.
8. (a) Flynn. G. A.; Beight, D. W.; Warshawsky, A. M.; Burkholder, T. P.; Mehdi, S.; Giroux, E. L.; Dage, R. C. Presented at the 203rd National Meeting of the American Chemical Society, San Francisco, CA, April 1992.
9. (b) Flynn, G. A.; Beight, D. W.; Mehdi, S.; Koehl, J. R.; Giroux, E. L.; French, J. F.; Hake, P. W.; Dage, R. C. J. Med. Chem. 1993, 36, 2420.
10. Flynn, G. A.; Beight, D. W.; Huber, E. W.; Bey, P. Tetrahedron Lett. 1990, 31, 815.
11. (a) Neustadt, B. World Patent WO 91/09840.
12. (b) Flynn G. A.; Beight, D. W.; US Patent 5, 252, 601, 1993.
13. Gross H.; Höft, E. Angew. Chem. 1969, 79, 358.
14. For the preparation of 3a see: Tomiyama, T.; Wakabayashi, S.; Yokata, M. J. Med. Chem. 1989, 32, 1988.
15. Turchaninova, L.P.; Voronkov, M. G.; Shipov, A. G.; Korchevin, N. A.; Baukov, Y. I.; Deryagina, E. N. Zh. Obshch. Khim. 1989, 59, 722. Experimental procedure for preparation of chloromethyl sulfides: To a mixture of 15.9 mL (125 mmol) TMSCl and 1.5 g (50 mmol) paraformaldehyde at 0 °C was added 7.0 mL (50 mmol) para-methoxybenzyl mercaptan. The mixture was stirred 2 h while warming to 20 °C, then distilled, bp 90-96 °C/0.1 torr. Yield: 3.5 g (34%).
16. Paterson, I.; Fleming, I. Tetrahedron Lett. 1979, 993.
17. See ref 10. bp 80-86 °C/75 torr. Yield: 60%.
18. Spevak, W.; Nagy, J. O.; Charych, D. H.; Shaefer, M. E.; Gilbert, J. H.; Bednarski, M. D. J. Am. Chem. Soc. 1993, 115, 1146.
19. Nishimura, O.; Kitada, C.; Fujino, M. Chem. Pharm. Bull. 1978, 26, 1576.
20. Greenstein, J. P.; Winitz, M. Chemistry of the Amino Acids; John Wiley and Sons: New York, 1961, pp 891-895.
21. For the preparation of 6e see: (a) Pearlman W. M. Org. Synth. Collect. Vol. 5; Baumgarten, H. E., Ed.; Wiley: New York, 1973; p 760.
22. (b) Johnston, T.P.; McCaleb G. S.; Clayton, S. D.; Frye, J. L.; Krauth, C. A.; Montgomery, J. A. J. Med. Chem. 1977, 20, 279.
23. French, J. F.; Flynn, G. A.; Giroux, E. L.; Mehdi, S.; Anderson, B.; Beach, D. C.; Koehl, J. R.; Dage, R. C. J. Pharmacol. Exp. Ther. 1994, 268, 180.
24. The enantiomers of 1b were separated on a cyclodextrin column. The (+) enantiomer eluted first and was purified to ∼96% ee. The (-) enantiomer was purified to ∼86% ee.
25. Benchetrit, T.; Fournié-Zaluskie, M. C.; Roques, B. P. Biochem. Biophys. Res. Commun. 1987, 147, 1034.